Cheminformatic Tools and Databases for Pharmacology

session 26195 - Total of 6 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
M PRASUGREL (is an active metabolite)

PRASUGREL


ATC B01AC22

BLOOD
ANTITHROMBOTIC AGENTS
P2Y(12) RECEPTOR ANTAGONIST
THIENOPYRIDINE

-

Tmax 0.5 HOUR

F 79 PERCENT

VD 56 LITER

PPB 98 PERCENT

Cl 139 LITER / HOUR

HT 7 HOUR

P2Y12 ADP RECEPTOR

PURINERGIC RECEPTOR P2Y12 ANTAGONIST CHEMBL2001 PURINERGIC RECEPTOR P2Y12 Q9H244 P2Y PURINOCEPTOR 12 HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL NUCLEOTIDE-LIKE RECEPTOR PURINE RECEPTOREMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

2 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
M PRASUGREL (is an active metabolite)

PRASUGREL


ATC B01AC22

BLOOD
ANTITHROMBOTIC AGENTS
P2Y(12) RECEPTOR ANTAGONIST
THIENOPYRIDINE

-

Tmax 0.5 HOUR

F 79 PERCENT

VD 56 LITER

PPB 98 PERCENT

Cl 139 LITER / HOUR

HT 7 HOUR

P2Y12 ADP RECEPTOR

PURINERGIC RECEPTOR P2Y12 ANTAGONIST CHEMBL2001 PURINERGIC RECEPTOR P2Y12 Q9H244 P2Y PURINOCEPTOR 12 HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL NUCLEOTIDE-LIKE RECEPTOR PURINE RECEPTOREMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

3 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
M PRASUGREL (is an active metabolite)

PRASUGREL


ATC B01AC22

BLOOD
ANTITHROMBOTIC AGENTS
P2Y(12) RECEPTOR ANTAGONIST
THIENOPYRIDINE

-

Tmax 0.5 HOUR

F 79 PERCENT

VD 56 LITER

PPB 98 PERCENT

Cl 139 LITER / HOUR

HT 7 HOUR

P2Y12 ADP RECEPTOR

PURINERGIC RECEPTOR P2Y12 ANTAGONIST CHEMBL2001 PURINERGIC RECEPTOR P2Y12 Q9H244 P2Y PURINOCEPTOR 12 HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL NUCLEOTIDE-LIKE RECEPTOR PURINE RECEPTOREMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

4 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
M PRASUGREL (is an active metabolite)

PRASUGREL


ATC B01AC22

BLOOD
ANTITHROMBOTIC AGENTS
P2Y(12) RECEPTOR ANTAGONIST
THIENOPYRIDINE

-

Tmax 0.5 HOUR

F 79 PERCENT

VD 56 LITER

PPB 98 PERCENT

Cl 139 LITER / HOUR

HT 7 HOUR

P2Y12 ADP RECEPTOR

PURINERGIC RECEPTOR P2Y12 ANTAGONIST CHEMBL2001 PURINERGIC RECEPTOR P2Y12 Q9H244 P2Y PURINOCEPTOR 12 HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL NUCLEOTIDE-LIKE RECEPTOR PURINE RECEPTOREMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

5 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
PRASUGREL (has an active metabolite)

PRASUGREL


ATC B01AC22

BLOOD
ANTITHROMBOTIC AGENTS
P2Y(12) RECEPTOR ANTAGONIST
THIENOPYRIDINE

ORAL

F 79 PERCENT

SOLUBILITY PRACTICALLY INSOLUBLE AT PH 6 TO 7.5

P2Y12 ADP RECEPTOR

PURINERGIC RECEPTOR P2Y12 ANTAGONIST CHEMBL2001 PURINERGIC RECEPTOR P2Y12 Q9H244 P2Y PURINOCEPTOR 12 HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL NUCLEOTIDE-LIKE RECEPTOR PURINE RECEPTOREMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

6 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
PRASUGREL (has an active metabolite)

PRASUGREL


ATC B01AC22

BLOOD
ANTITHROMBOTIC AGENTS
P2Y(12) RECEPTOR ANTAGONIST
THIENOPYRIDINE

ORAL

F 79 PERCENT

SOLUBILITY PRACTICALLY INSOLUBLE AT PH 6 TO 7.5

P2Y12 ADP RECEPTOR

PURINERGIC RECEPTOR P2Y12 ANTAGONIST CHEMBL2001 PURINERGIC RECEPTOR P2Y12 Q9H244 P2Y PURINOCEPTOR 12 HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL NUCLEOTIDE-LIKE RECEPTOR PURINE RECEPTOREMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |